Transpek Industry Vergangene Ertragsentwicklung
Vergangenheit Kriterienprüfungen 1/6
Transpek Industry's earnings have been declining at an average annual rate of -1.6%, while the Chemicals industry saw earnings growing at 15.6% annually. Revenues have been growing at an average rate of 6.5% per year. Transpek Industry's return on equity is 4.8%, and it has net margins of 5.6%.
Wichtige Informationen
-1.6%
Wachstumsrate der Gewinne
-2.5%
EPS-Wachstumsrate
| Chemicals Wachstum der Industrie | 17.7% |
| Wachstumsrate der Einnahmen | 6.5% |
| Eigenkapitalrendite | 4.8% |
| Netto-Marge | 5.6% |
| Nächste Ertragsaktualisierung | 13 Nov 2024 |
Jüngste Aktualisierungen vergangener Leistungen
Recent updates
Aufschlüsselung der Einnahmen und Ausgaben
Wie Transpek Industry Geld verdient und ausgibt. Basierend auf den neuesten gemeldeten Einnahmen der letzten zwölf Monate.
Gewinn- und Umsatzhistorie
| Datum | Einnahmen | Umsatz | Allgemeine und Verwaltungskosten | F&E-Ausgaben |
|---|---|---|---|---|
| 30 Jun 24 | 5,693 | 320 | 623 | 0 |
| 31 Mar 24 | 5,867 | 386 | 627 | 0 |
| 31 Dec 23 | 6,410 | 553 | 616 | 0 |
| 30 Sep 23 | 6,892 | 639 | 622 | 0 |
| 30 Jun 23 | 7,844 | 829 | 627 | 0 |
| 31 Mar 23 | 8,338 | 835 | 613 | 0 |
| 31 Dec 22 | 7,716 | 724 | 577 | 0 |
| 30 Sep 22 | 7,552 | 707 | 551 | 0 |
| 30 Jun 22 | 6,889 | 683 | 532 | 0 |
| 31 Mar 22 | 6,039 | 654 | 517 | 0 |
| 31 Dec 21 | 5,464 | 650 | 496 | 0 |
| 30 Sep 21 | 4,761 | 501 | 479 | 0 |
| 30 Jun 21 | 4,090 | 331 | 457 | 0 |
| 31 Mar 21 | 3,455 | 233 | 452 | 0 |
| 31 Dec 20 | 4,176 | 366 | 481 | 0 |
| 30 Sep 20 | 4,923 | 585 | 491 | 0 |
| 30 Jun 20 | 5,443 | 734 | 486 | 0 |
| 31 Mar 20 | 5,793 | 729 | 507 | 0 |
| 31 Dec 19 | 5,855 | 788 | 588 | 0 |
| 30 Sep 19 | 5,861 | 633 | 572 | 0 |
| 30 Jun 19 | 5,928 | 585 | 564 | 0 |
| 31 Mar 19 | 6,096 | 657 | 547 | 0 |
| 31 Mar 18 | 3,666 | 264 | 413 | 0 |
| 31 Mar 17 | 3,166 | 300 | 381 | 0 |
| 31 Mar 16 | 2,837 | 213 | 351 | 0 |
| 31 Mar 15 | 2,896 | 220 | 330 | 0 |
| 31 Mar 14 | 2,692 | 75 | 529 | 0 |
Qualität der Erträge: 506687 has high quality earnings.
Wachsende Gewinnspanne: 506687's current net profit margins (5.6%) are lower than last year (10.6%).
Analyse von freiem Cashflow und Gewinn
Analyse des Gewinnwachstums in der Vergangenheit
Ergebnisentwicklung: 506687's earnings have declined by 1.6% per year over the past 5 years.
Beschleunigtes Wachstum: 506687's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Erträge im Vergleich zur Industrie: 506687 had negative earnings growth (-61.4%) over the past year, making it difficult to compare to the Chemicals industry average (10.4%).
Eigenkapitalrendite
Hohe Eigenkapitalrendite: 506687's Return on Equity (4.8%) is considered low.